Literature DB >> 26210225

Time trends of clinicopathologic features and surgical treatment for gastric cancer: Results from 2 high-volume institutions in southern China.

Wei Wang1, Chaohui Zheng2, Cheng Fang1, Ping Li2, Jianwei Xie2, Jianxian Lin2, Youqing Zhan1, Wei Li1, Yingbo Chen1, Xiaowei Sun1, Dazhi Xu1, Yuanfang Li1, Changming Huang3, Zhiwei Zhou4.   

Abstract

BACKGROUND: The objective of this study was to evaluate the time-related trends of tumor characteristics and postoperative survival of patients with gastric cancer (GC) in 2 high-volume centers in high incidence areas of southern China.
METHODS: Based on the meticulously collected data from 5,327 patients with GC treated with operative intervention at Sun Yat-sen University Cancer Center and Fujian Medical University Union Hospital, we analyzed the differences in clinicopathologic features and postoperative survival over the following 4 consecutive periods: 1991-1995 (period 1), 1996-2000 (period 2), 2001-2005 (period 3), and 2006-2010 (period 4).
RESULTS: Tumor size decreased (P = .001), but the proportion of poorly differentiated tumors increased (P < .001) over the study periods. Early GC was diagnosed more often in later periods, gradually increasing from 7 to 15% (P < .001). A surprising improvement was observed in the mean number of retrieved lymph nodes, ranging from 10.36 to 26.22 (P < .001). The radical resection rate increased from 88 to 93%. The overall 5-year survival rate improved steadily over the 4 periods, from 39 to 53% (P < .001). Multivariate analysis revealed that age, tumor location, histologic type, tumor size, depth of invasion, lymphatic invasion, number of retrieved lymph nodes, radical resection, and time periods were independent prognostic factors.
CONCLUSION: The clinicopathologic features of tumors changed during the observation period in our region. The increasingly early detection of patients with GC and more standardized regimens for operative management, including routinely performed D2 lymphadenectomy, most likely resulted in the increase in overall survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26210225     DOI: 10.1016/j.surg.2015.04.038

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  The Role of No. 10 Lymphadenectomy for Advanced Proximal Gastric Cancer Patients Without Metastasis to No. 4sa and No. 4sb Lymph Nodes.

Authors:  Shibo Bian; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Liangang Ma; Rong Chen; Bo Wei; Lin Chen
Journal:  J Gastrointest Surg       Date:  2016-03-03       Impact factor: 3.452

3.  Short and long-term outcomes after proximal gastrectomy with double tract reconstruction for Siewert type III adenocarcinoma of the esophagogastric junction: a propensity score matching study from a 10-year experience in a high-volume hospital.

Authors:  Fei Ma; Dandan Guo; Bin Zhang; Yonglei Zhang; Liangqun Peng; Qi Ma; Sheqing Ji; Junhui Chai; Yawei Hua; Xiaobing Chen; Hui Wang; Shuning Xu; Suxia Luo
Journal:  J Gastrointest Oncol       Date:  2020-12

4.  Learning curve for gastric cancer patients with laparoscopy-assisted distal gastrectomy: 6-year experience from a single institution in western China.

Authors:  Lin-Yong Zhao; Wei-Han Zhang; Yan Sun; Xin-Zu Chen; Kun Yang; Kai Liu; Xiao-Long Chen; Yi-Gao Wang; Xiao-Hai Song; Lian Xue; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

5.  Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer.

Authors:  Jinou Wang; Pei Wu; Zhenning Wang; Kai Li; Baojun Huang; Pengliang Wang; Huimian Xu; Zhi Zhu
Journal:  Chin J Cancer Res       Date:  2019-02       Impact factor: 5.087

6.  The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy.

Authors:  Kai Zhou; Anqiang Wang; Jingtao Wei; Ke Ji; Zhongwu Li; Xin Ji; Tao Fu; Ziyu Jia; Xiaojiang Wu; Ji Zhang; Zhaode Bu
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

7.  Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer: Analysis from a Large-Scale Cohort.

Authors:  Cheng-Le Zhuang; Dong-Dong Huang; Wen-Yang Pang; Chong-Jun Zhou; Su-Lin Wang; Neng Lou; Liang-Liang Ma; Zhen Yu; Xian Shen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer.

Authors:  Ming-Zhe Ma; Shu-Qiang Yuan; Yong-Ming Chen; Zhi-Wei Zhou
Journal:  Onco Targets Ther       Date:  2018-04-13       Impact factor: 4.147

9.  Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial.

Authors:  Zaozao Wang; Jiadi Xing; Jun Cai; Zhongtao Zhang; Fei Li; Nengwei Zhang; Jixiang Wu; Ming Cui; Ying Liu; Lei Chen; Hong Yang; Zhi Zheng; Xiaohui Wang; Chongchong Gao; Zhe Wang; Qing Fan; Yanlei Zhu; Shulin Ren; Chenghai Zhang; Maoxing Liu; Jiafu Ji; Xiangqian Su
Journal:  Surg Endosc       Date:  2018-11-01       Impact factor: 4.584

10.  Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.

Authors:  Mengyu Sun; Jieping Qiu; Huazheng Zhai; Yaoqun Wang; Panpan Ma; Mengyin Li; Bo Chen
Journal:  Med Sci Monit       Date:  2020-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.